Ikarian Capital, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $24,093 - $30,554	2,692 Added 1.92%	142,692 $1.37 Million
Q1 2023 May 15, 2023	BUY	$6.3 - $8.39 $882,000 - $1.17 Million	140,000 New	140,000 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$8.16 - $15.1 $324,196 - $599,923	-39,730 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.2 - $16.97 $35,324 - $53,523	3,154 Added 8.62%	39,730 $586,000
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $741,600 - $1.1 Million	-60,000 Reduced 62.13%	36,576 $484,000
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $6,655 - $9,526	-389 Reduced 0.4%	96,576 $1.69 Million
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $4.62 Million - $5.98 Million	-200,000 Reduced 67.35%	96,965 $2.32 Million
Q1 2021 May 17, 2021	SELL	$14.69 - $42.57 $11.3 Million - $32.7 Million	-766,996 Reduced 72.09%	296,965 $7.63 Million
Q4 2020 Feb 12, 2021	SELL	$12.88 - $19.47 $2.21 Million - $3.34 Million	-171,510 Reduced 13.88%	1,063,961 $20.2 Million
Q3 2020 Nov 16, 2020	BUY	$9.83 - $13.99 $1.2 Million - $1.71 Million	122,076 Added 10.96%	1,235,471 $15.6 Million
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $1.13 Million - $2.15 Million	166,790 Added 17.62%	1,113,395 $13.5 Million
Q1 2020 May 15, 2020	BUY	$5.8 - $18.56 $4.26 Million - $13.6 Million	734,185 Added 345.63%	946,605 $7.24 Million
Q4 2019 Jan 31, 2020	BUY	$10.31 - $17.81 $2.19 Million - $3.78 Million	212,420 New	212,420 $3.78 Million

126

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $214M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.